Greater Cannabis Company (GCAN) Revenue Growth (3y) (2020 - 2021)

Greater Cannabis Company (GCAN) Revenue Growth (3y) (2020 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Haleon 89.60 Bn 87.73 Bn - -
2 Teva Pharmaceutical Industries 35.91 Bn 32.16 Bn 1.97 Bn 2.84%
3 Zoetis 32.46 Bn 30.52 Bn 1.62 Bn 4.19%
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn -4.46%
5 United Therapeutics 23.13 Bn 20.98 Bn 648.10 Mn 15.52%
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn -2.00%
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn 24.66%
9 Elanco Animal Health 12.60 Bn 12.18 Bn 785.00 Mn 2.94%
10 Greater Cannabis Company 236,233.75 234,794.75 - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -17.46%
Jun 30, 2020 769.84%